# Deciphering the Role of Postbiotics Derived from Bacillus subtilis natto on LPS-Induced Endothelial Cell Dysfunction

**Authors:** Róbert Szendi, Endre Szilágyi, Mária Magdolna Szarvas, Ildikó Kovács-Forgács, Judit Rita Homoki, Georgina Pesti-Asbóth, Erzsébet Szőllősi, Mónika Éva Fazekas, Zoltán Cziáky, János Lukács, László Stündl, Emese Szilágyi-Tolnai, Judit Remenyik

PMC · DOI: 10.3390/biomedicines14020293 · Biomedicines · 2026-01-28

## TL;DR

This study shows that postbiotics from Bacillus subtilis natto protect endothelial cells from inflammation caused by LPS, reducing cell damage and inflammation.

## Contribution

The study is the first to demonstrate the cytoprotective and anti-inflammatory effects of postbiotics from Bacillus subtilis natto in LPS-induced endothelial dysfunction.

## Key findings

- Postbiotics significantly reduced LPS-induced apoptosis and restored mitochondrial and cell viability.
- Postbiotics decreased ROS accumulation and suppressed the upregulation of inflammatory cytokines like IL-6 and IL-8.
- Postbiotics modulated HSP and NF-κB responses, mitigating LPS-induced endothelial inflammation.

## Abstract

Background: This study aimed to assess the effects of postbiotic derived from Bacillus subtilis natto (Szendi2020) on endothelial responses under LPS-induced inflammatory stress. Methods: In human umbilical vein endothelial cells (HUVECs), inflammation was induced with 200 ng/mL LPS. Cell viability, apoptosis, and mitochondrial integrity were assessed using MTT assay, DiIC, and Sytox Green permeability assays. Intracellular ROS levels, heat shock proteins (HSPB1/Hsp27, HSPA1L/Hsp70), adhesion molecules (ICAM-1, VCAM-1), tight junction protein (Occludin), transcription regulators (NF-κB, TNFα), and proinflammatory cytokines (IL-1β, IL-6, IL-8) were quantified using qPCR and ELISA. Results: LPS exposure significantly induced apoptosis in HUVECs, as reflected by decreased metabolic activity, decreased mitochondrial membrane potential, and increased cell death (p < 0.05). Concurrent postbiotic administration completely abolished LPS-induced cytotoxicity in all assay platforms, demonstrating a potent cytoprotective effect. Postbiotic treatment significantly reduced LPS-induced ROS accumulation (p < 0.05). LPS significantly increased Hsp27 and Hsp70 mRNA expression. However, combined LPS and postbiotic exposure mitigated Hsp27 and Hsp70 mRNA expression compared with LPS treatment alone (p < 0.001, p < 0.005). Postbiotic treatment also decreased the upregulation of adhesion molecules induced by LPS. Although this effect decreased after 24 h (p < 0.001). LPS strongly increased NF-κB, IL-1β and TNFα mRNA levels and was suppressed by postbiotics at early time points but not maintained over 24 h. Importantly, postbiotics significantly reduced IL-6, and IL-8 expression at both the mRNA and protein levels, highlighting the attenuation of endothelial inflammatory features (p < 0.05, p < 0.005, p < 0.001). Conclusions: Our results are the first to demonstrate that postbiotics derived from Bacillus subtilis natto (Szendi2020) exert potent cytoprotective and anti-inflammatory effects in LPS-induced endothelial inflammation. By reducing ROS accumulation, preventing apoptosis, stabilizing mitochondrial and barrier integrity, modulating HSP, NF-κB, and cytokine responses. Postbiotics may be promising therapeutic candidates for alleviating endothelial inflammation and the resulting endothelial dysfunction.

## Linked entities

- **Genes:** HSPB1 (heat shock protein family B (small) member 1) [NCBI Gene 3315], HSPA1L (heat shock protein family A (Hsp70) member 1 like) [NCBI Gene 3305], ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383], VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412], si:ch73-61d6.3 (uncharacterized si:ch73-61d6.3) [NCBI Gene 103182021], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], TNF (tumor necrosis factor) [NCBI Gene 7124], IL1B (interleukin 1 beta) [NCBI Gene 3553], IL6 (interleukin 6) [NCBI Gene 3569], CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576]
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CSF3 (colony stimulating factor 3) [NCBI Gene 1440] {aka C17orf33, CSF3OS, GCSF}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** hypoxia (MESH:D000860), metabolic disorders (MESH:D008659), Necrosis (MESH:D009336), acute (MESH:D000208), dysfunction (MESH:D006331), acute stroke (MESH:D020521), inflammatory cytokine (MESH:D000080424), obesity (MESH:D009765), heart failure (MESH:D006333), cytotoxic (MESH:D064420), CVD (MESH:D002318), myocardial infarction (MESH:D009203), diabetes (MESH:D003920), ED (MESH:D014652), ischemic heart disease (MESH:D017202), gut dysbiosis (MESH:D064806), Necrotic Cell Death (MESH:D003643), hypertension (MESH:D006973), mitochondrial dysfunction (MESH:D028361), Atherosclerosis (MESH:D050197), acute coronary syndrome (MESH:D054058), Inflammatory (MESH:D007249), injury to (MESH:D014947), hyperglycemia (MESH:D006943), hyperlipidemia (MESH:D006949)
- **Chemicals:** NO (MESH:D009569), indole (MESH:C030374), ethanol (MESH:D000431), ROS (MESH:D017382), SCFAs (MESH:D005232), PBS (MESH:D007854), SYTOX Green (MESH:C402795), HCl (MESH:D006851), 2-propanol (MESH:D019840), lipid (MESH:D008055), DCFDA (MESH:C029569), LPS (MESH:D008070), water (MESH:D014867), glutamine (MESH:D005973), Lipopeptides (MESH:D055666), CO2 (MESH:D002245), Triton X-100 (MESH:D017830), trifluoroacetic acid (MESH:D014269), menaquinone (MESH:D024482), acetonitrile (MESH:C032159), carbon (MESH:D002244), streptomycin (MESH:D013307), amphotericin B (MESH:D000666), MTT (MESH:C070243), amino acids (MESH:D000596), phosphoric acid (MESH:C030242), formic acid (MESH:C030544), hexane (MESH:D006586), n-hexane (MESH:C026385), formazan (MESH:D005562), PTFE (MESH:D011138), penicillin (MESH:D010406), 1,1',3,3,3',3'-hexamethylindodicarbocyanine iodide (MESH:C067566), Endothelial Cell Growth Medium-2 (-), methanol (MESH:D000432)
- **Species:** gut metagenome (species) [taxon 749906], Bacillus subtilis subsp. natto (subspecies) [taxon 86029], Homo sapiens (human, species) [taxon 9606], Bacillus subtilis (species) [taxon 1423]
- **Cell lines:** HUVEC-TERT — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_9Q53), vein — Homo sapiens (Human), Finite cell line (CVCL_3722)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938160/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938160/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938160/full.md

---
Source: https://tomesphere.com/paper/PMC12938160